Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Lasers and light treatments are now the most common ways to remove hair.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Vitamin D might help treat some types of hair loss, but more research is needed.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.